bioecon Раздел для участников
Поставщики · Производитель · Найдена — похожая действующая компания

Amyris

Amyris — вертикально интегрированная биотехнологическая компания: методом ферментации производит специальные молекулы для ароматизаторов и парфюмерии, материалов, косметики и средств ухода, пищевых продуктов и др. Основана в 2003 г. ради биотехнологического производства противомалярийного вещества.

работает СШАСША и Канада Основана 2003 не на бирже проверено 2026-10-05

Профиль

Отрасль
Косметика, Пищевые ингредиенты, Промышленная химия
Темы
Платформы синтетической биологии и биопроизводство, Дрожжи, ферментация и пищевые ингредиенты
Роль
Производитель — “…is customizes, creates, and manufactures | Amyris is a vertically integrated biomanufacturing company that use…”
Почему это биоэкономика
Amyris производит специальные молекулы для разных отраслей методами прецизионной ферментации и синтетической биологии.
Как найдена
Codexis; Ginkgo Bioworks; Geno; Solugen

Биорешения, которые поставляет 0

Пока не указана поставщиком в решениях с доказательствами.

Проверенные совпадения продуктов: Reb M → FI02;

Что предлагают

Компания не публикует продукты и услуги — узнаем через знакомство.

Бизнес-модель · cautionary

Amyris was a synthetic biotechnology company that utilized its proprietary Lab-to-Market platform to engineer microbes for the production of sustainable, high-value ingredients through precision fermentation. It earned revenue by selling these ingredients in bulk to industrial partners in sectors like flavors, fragrances, and nutrition, and by marketing its own portfolio of clean beauty and wellness consumer brands directly to consumers and through retail partners. Additionally, the company generated income through R&D collaborations, technology licensing, and profit-sharing agreements with strategic partners.

Renewable Products, License fees and royalties, Collaboration and grants 2022
In fiscal year 2022, Amyris reported revenue segments of Renewable Products (82%), License fees and royalties (12%), and Collaboration and grants (6%).
“AMRS reports revenue from Renewable Products (chemicals used in beauty products); (87% of 4Q22 revenue and 82% of FY22 revenue); License fees and royalties (9% and 12%); and Collaboration and grants (4% and 6%).”
ionanalytics.com weak (company, news, market research, other)
2022
Amyris reported total revenue of $270 million and an adjusted EBITDA of negative $521 million for the fiscal year 2022.
“In FY22, revenue fell 21% YoY to USD 270m due to the absence of large licence transaction.... Despite growth in revenue, adjusted EBITDA deteriorated to negative USD 157m in 4Q22 and negative USD 521m in FY22, affected …”
ionanalytics.com weak (company, news, market research, other)
2022
Amyris's R&D and SG&A expenses increased significantly over the two years leading up to 2022, driven by a three-fold increase in headcount and higher operational costs.
“It is important to note that the company’s headcount despite operating at negative EBITDA has increased around three-fold to 1,598 as of 4Q22 (FY21: 980, FY20: 595). As a result, R&D and SG&A expenses increased …”
ionanalytics.com weak (company, news, market research, other)
2022
In 2022, Amyris derived 73% of its revenue from North America, 16% from Europe, 7% from Asia, 2% from South America, and 1% from other locations.
“Geographically, AMRS derives revenue from North America (73% of FY22 revenue), Europe (16%), Asia (7%), South America (2%) and other locations (1%).”
ionanalytics.com weak (company, news, market research, other)
2023
Amyris filed for Chapter 11 bankruptcy in August 2023 to restructure its finances and operations.
“To facilitate the restructuring, Amyris and certain of its domestic subsidiaries commenced voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware (the "Court").”
www.prnewswire.com weak (company, news, market research, other)
Squalane 2023
Amyris Squalane replaced shark-derived squalane in the cosmetic ingredient sector.
“How rock-steady consistency and high performance of Amyris Squalane enabled us to overcome barriers to global market adoption and become the most broadly-accepted alternative to shark-derived squalane in the cosmetic …”
www.amyris.com weak (company, news, market research, other)
Bisabolol
Amyris Bisabolol replaced Candeia-tree derived bisabolol and synthetic petrochemical-derived bisabolol.
“Using engineered yeast strains, Amyris converts renewable and ethically sourced sugarcane into bisabolol at the industrial scale, eliminating reliance upon vulnerable ecosystems, eliminating product variability, and …”
www.amyris.com weak (company, news, market research, other)
Farnesene
Amyris Farnesene replaced petrochemical building blocks in various performance materials.
“Across the production lifecycle, our farnesene boasts a 50-60% reduction in CO 2 emissions relative to similar petrochemical feedstocks, even before all biogenic carbon credits are considered.”
www.amyris.com weak (company, news, market research, other)
Farnesene (as a building block for Vitamin E)
Amyris Farnesene used as a building block for Vitamin E replaced traditional synthetic pathways.
“Beyond performance materials, the use of Amyris’ farnesene as a building block for Vitamin E resulted in a 35% decrease in production cost by dramatically reducing complexity of the synthetic pathway.”
www.amyris.com weak (company, news, market research, other)
Reb M
Amyris Reb M replaced traditional plant harvesting of Stevia.
“Amyris Reb M starts out pure thus does not require the costly purification process of traditional plant harvesting”
filecache.investorroom.com weak (company, news, market research, other)
Farnesane (renewable diesel)
Amyris renewable diesel (farnesane) replaced petroleum-based diesel.
“Among its many advantages as a diesel fuel farnesane provides at least an 80% reduction of greenhouse gas emissions relative to petroleum-based diesel (based on California Air Resources Board metrics), zero sulfur …”
scielo.br peer-reviewed

Новости и статус 6

Связи: владельцы, партнёры, аналоги

Владельцы и инвесторы 1

материнскаяindependent

Партнёры и сделки 2

сторона сделкиLender groups affiliated with Foris Ventures
…Amyris emerged from Chapter 11 bankruptcy protection in May 2024 as a privately held company.…
производственный партнёрAs of 2026
…nich, Croda, and Wacker. As of 2026, Amyris remains active, focusing on licensing, contract manufacturing, and in-house product development. <details><summary>Profile sources</summary>…

Похожие компании

Sensient Technologies Corporation · Bell Flavors & Fragrances · Greenfield Global · Wisconsin BioProducts · Conagen · CP Kelco · Geno · Jeneil Biotech, Inc.

Реквизиты и контакты

Контакты, руководители и юридические данные доступны участникам.

Войти как участник